Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Sign in
Join now
Jonathan Silberstein MD, MBA

Jonathan Silberstein MD, MBA

Chief of Urologic Oncology, Memorial Health System, Broward, Florida

Biographical Sketch:

Jonathan Silberstein earned his medical degree at SUNY Upstate Medical University in Syracuse, New York. He completed his general surgery internship and his urology residency at the University of California in San Diego. Following his residency, Dr. Silberstein completed a 3-year fellowship in urologic oncology at Memorial Sloan Kettering Cancer Center in New York. He joined the faculty of Tulane University School of Medicine in 2013 and was the Director of Urologic Oncology at Tulane and the Assistant Chief of Urology at the Southeast Louisiana Veterans Affairs Hospital. He is the author of more than 60 peer-reviewed publications and several book chapters.He is now the Chief of Urologic Oncology Memorial Health System, Broward Florida.

He is also the winner of numerous awards from national and international meetings and is a reviewer for several prominent urologic journals.

Positions:

Assistant Professor of Urology; Chief, Section of Urologic Oncology, Department of Urology, Tulane University School of Medicine; Chief of Urology Service, Department of Surgery, Southeast Louisiana Veterans Health Care Center, New Orleans, Louisiana
Degrees:

MD: SUNY Upstate Medical University, Syracuse, New York

Postgraduate Training:

Fellowship (urologic oncology): Memorial Sloan Kettering Cancer Center, New York, New York

Clinical Interests:

Advanced urologic malignancies

Research Interests:

Clinical trial design and implementation, 3D printing physical models of urologic malignancies

Recent Contributions to PracticeUpdate:

  1. The Incidence and Relative Risk of Cardiovascular Toxicity in Patients Treated With New Hormonal Agents for Castration-Resistant Prostate Cancer
  2. The Heterogeneity of High-Risk Prostate Cancer
  3. Smokers at Increased Risk for Biochemical Recurrence Post Prostatectomy
  4. Genomics Helps Identify Post-Prostatectomy Patients at Higher Risk for Recurrence, Metastasis, and Death
  5. Perioperative Outcomes After Radical Prostatectomy for Distant Metastatic Prostate Cancer at Presentation
  6. Urinary Complications From Metastatic Prostate Cancer
  7. Imperative to Up the Representation of African Americans in Trials of CRPC
  8. Factors Associated With Worse Outcomes From Salvage Prostatectomy
  9. Disparities in Castration-Resistant Prostate Cancer Trials
  10. Increased Disease Recurrence After Prostatectomy in Black Patients With Low-Grade Prostate Cancer

Elsewhere

Recently Updated